This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

12 Dec 2011

New Pharma Database Expected to Facilitate Drug Development

Several life-sciences organisations have worked on the project with IBM Research gaining access to a chemical library extracted from worldwide patents and scientific abstracts.

A database jointly established by Bristol-Myers Squibb, DuPont and Pfizer contains over 2.4 million chemical compounds extracted from 4.7 million patents and 11 million biomedical journal abstracts from 1976 to 2000.


A new cloud-based analytics software tool, IBM Strategic IP Insight Platform, will be used to extract the data.


Steve Heller project director for the InChI Trust, which supports the InChI international standard to represent chemical structures said, that the scientific community would receive "enormous benefit" from this advancement. "The comprehensiveness of the data and the new ways researchers can look at these data, and cross-link to other data associated with each chemical, is expected to help with drug development to

Related News